MEG3 and glioma: Although, neither navitoclax (Nvtx) nor 5‐fluorouracil (5FU) are available for standard glioma treatment, the aim of this study was to sensitize glioma cells to drugs currently in use and approved for chemotherapeutic activity and to evaluate their use in the treatment of glioma by modulating the MEG3 gene expression.